Omega Healthcare Investors, Inc. (NYSE:OHI) Receives Consensus Recommendation of “Hold” from Brokerages

Shares of Omega Healthcare Investors, Inc. (NYSE:OHI) have received a consensus rating of “Hold” from the fourteen research firms that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have issued a buy rating on the company. The average 12 month price target among analysts that have covered the stock in the last year is $49.1667.

A number of analysts recently commented on the company. Cantor Fitzgerald raised their price target on Omega Healthcare Investors from $50.00 to $52.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 10th. Scotiabank increased their price target on shares of Omega Healthcare Investors from $48.00 to $50.00 and gave the stock a “sector perform” rating in a research note on Thursday, May 21st. Citigroup increased their price target on shares of Omega Healthcare Investors from $50.00 to $52.00 and gave the stock a “buy” rating in a research note on Friday, May 1st. Truist Financial increased their price target on shares of Omega Healthcare Investors from $46.00 to $48.00 and gave the stock a “hold” rating in a research note on Thursday, March 5th. Finally, Weiss Ratings downgraded shares of Omega Healthcare Investors from a “buy (a-)” rating to a “buy (b+)” rating in a research note on Tuesday.

Omega Healthcare Investors Stock Performance

NYSE:OHI opened at $44.53 on Friday. The business has a 50 day moving average price of $46.28 and a 200-day moving average price of $45.72. Omega Healthcare Investors has a fifty-two week low of $35.70 and a fifty-two week high of $49.33. The firm has a market cap of $13.26 billion, a PE ratio of 21.51, a price-to-earnings-growth ratio of 1.91 and a beta of 0.58. The company has a debt-to-equity ratio of 0.81, a quick ratio of 5.32 and a current ratio of 5.32.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings results on Tuesday, April 28th. The real estate investment trust reported $0.47 EPS for the quarter, missing analysts’ consensus estimates of $0.49 by ($0.02). Omega Healthcare Investors had a return on equity of 11.86% and a net margin of 51.14%.The business had revenue of $322.96 million during the quarter, compared to analysts’ expectations of $264.07 million. During the same period in the previous year, the business earned $0.75 EPS. The business’s revenue was up 16.7% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2026 guidance at 3.190-3.250 EPS. Equities research analysts predict that Omega Healthcare Investors will post 3.07 earnings per share for the current year.

Omega Healthcare Investors Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 15th. Investors of record on Monday, May 4th were paid a $0.67 dividend. This represents a $2.68 dividend on an annualized basis and a yield of 6.0%. The ex-dividend date of this dividend was Monday, May 4th. Omega Healthcare Investors’s dividend payout ratio is presently 129.47%.

Hedge Funds Weigh In On Omega Healthcare Investors

A number of institutional investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in Omega Healthcare Investors by 3.4% in the third quarter. Vanguard Group Inc. now owns 42,152,368 shares of the real estate investment trust’s stock worth $1,779,673,000 after purchasing an additional 1,386,887 shares in the last quarter. State Street Corp raised its holdings in Omega Healthcare Investors by 4.8% in the second quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust’s stock worth $534,792,000 after purchasing an additional 671,473 shares in the last quarter. Geode Capital Management LLC raised its holdings in Omega Healthcare Investors by 9.4% in the fourth quarter. Geode Capital Management LLC now owns 8,515,924 shares of the real estate investment trust’s stock worth $377,648,000 after purchasing an additional 734,774 shares in the last quarter. Invesco Ltd. raised its holdings in Omega Healthcare Investors by 8.6% in the fourth quarter. Invesco Ltd. now owns 5,368,945 shares of the real estate investment trust’s stock worth $238,059,000 after purchasing an additional 424,024 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. raised its holdings in Omega Healthcare Investors by 4.1% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,463,838 shares of the real estate investment trust’s stock worth $197,927,000 after purchasing an additional 174,062 shares in the last quarter. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.